This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Feb;49(2):689-90.

doi: 10.1002/hep.22770.

Insights into defibrotide as therapy for veno-occlusive disease

Jennifer R Gamble¹, Mathew A Vadas

Affiliations

PMID: 19177563
DOI: 10.1002/hep.22770

Comment

Insights into defibrotide as therapy for veno-occlusive disease

Jennifer R Gamble et al. Hepatology. 2009 Feb.

. 2009 Feb;49(2):689-90.

doi: 10.1002/hep.22770.

Authors

Jennifer R Gamble¹, Mathew A Vadas

Affiliation

¹ Vascular Biology Program, Centenary Institute, University of Sydney, New South Wales, Australia.

PMID: 19177563
DOI: 10.1002/hep.22770

No abstract available

PubMed Disclaimer

Comment on

Angiogenesis alteration by defibrotide: implications for its mechanism of action in severe hepatic veno-occlusive disease.
Benimetskaya L, Wu S, Voskresenskiy AM, Echart C, Zhou JF, Shin J, Iacobelli M, Richardson P, Ayyanar K, Stein CA. Benimetskaya L, et al. Blood. 2008 Nov 15;112(10):4343-52. doi: 10.1182/blood-2008-04-149682. Epub 2008 Aug 18. Blood. 2008. PMID: 18711003

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley